|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,095 KRW | 0.00% |
|
+1.21% | -8.32% |
MYUNGMOON Pharm co.,Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 7,668.41 million compared to KRW 12,016.74 million a year ago. Net loss was KRW 6,864.5 million compared to KRW 27,638.59 million a year ago.
Basic loss per share from continuing operations was KRW 203 compared to KRW 944 a year ago. Basic loss per share was KRW 203 compared to KRW 944 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.32% | 51.86M | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
MYUNGMOON PHARM CO.,LTD 
